Combination of transarterial therapy with sorafenib for hepatocellular carcinoma.

被引：1
|
作者：
Cabrera, R.
Pannu, D. S.
Caridi, J.
Firpi, R.
Soldevila-Pico, C.
Morelli, G.
Clark, V.
George, T. J.
Nelson, D.
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
[2] Univ Florida, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14598
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14598
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [22] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
  • [23] Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta-analysis
    Li, Yong
    Liu, Xingyu
    Liu, Junning
    Yang, Linfeng
    Wei, Song
    Li, Jijiang
    Gan, Huixin
    Ma, Ting
    Yi, Pengsheng
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [24] Efficacy of Combination Therapy (in Addition to Sorafenib) in hepatocellular Carcinoma (HCC) after Progress under local Tumor Therapy by transarterial Chemoembolization (TACE)
    Johanniemann, K.
    Werner, T.
    Breitfeld, P.
    Lohse, A.
    Koops, A.
    Wege, H.
    INTERNIST, 2013, 54 : 31 - 31
  • [25] Long-term survivors after sorafenib therapy in unresectable hepatocellular carcinoma.
    Imura, Satoru
    Shimada, Mitsuo
    Morine, Yuji
    Ikemoto, Tetsuya
    Arakawa, Yusuke
    Iwahashi, Shuichi
    Saito, Yu
    Yamada, Shinichiro
    Shibata, Hiroshi
    Miyake, Hidenori
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [26] Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation
    Peng, Zhenwei
    Chen, Shuling
    Wei, Mengchao
    Lin, Manxia
    Jiang, Chunlin
    Mei, Jie
    Li, Bin
    Wang, Yu
    Li, Jiaping
    Xie, Xiaoyan
    Chen, Minshan
    Qian, Guojun
    Kuang, Ming
    RADIOLOGY, 2018, 287 (02) : 705 - 714
  • [27] Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis
    Duan, Feng
    Wang, Mao Qiang
    Liu, Feng Yong
    Wang, Zhi Jun
    Song, Peng
    Wang, Yan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (02) : 156 - 163
  • [28] Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
    Song, Myeong Jun
    Bae, Si Hyun
    Lee, June Sung
    Lee, Sung Won
    Song, Do Seon
    You, Chan Ran
    Choi, Jong Young
    Yoon, Seung Kew
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (02): : 242 - 252
  • [29] Combination of transarterial chemoembolization and percutaneous local ablation therapy for hepatocellular carcinoma
    Imai, Yasuharu
    HEPATOLOGY RESEARCH, 2010, 40 (01) : 105 - 107
  • [30] Regorafenib Combination Therapy in Advanced Hepatocellular Carcinoma: With or without Transarterial Chemoembolization
    Cao, Lei
    Lu, Xiangyu
    Chen, Haoqing
    Yu, Xiang
    Li, Jinze
    Peng, Yi
    Gu, Lu
    Feng, Ji
    Xie, Ping
    Liu, Yaben
    ONCOLOGY, 2024,
12345